말 건강관리 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Equine Healthcare Market size is expected to reach USD 5.45 Billion in 2034 from USD 2.87 Billion (2025) growing at a CAGR of 7.39% during 2026-2034.

The Global Equine Healthcare Market is gaining momentum as the importance of horse health and veterinary care continues to increase. Horses are widely used in sports, racing, agriculture, and recreational activities, making their health management a priority for owners and trainers. The rising number of equine veterinary clinics and improved awareness of preventive healthcare practices are driving the demand for advanced equine healthcare products and services.

Key market drivers include the increasing adoption of vaccines, diagnostic tools, nutritional supplements, and pharmaceutical treatments designed specifically for horses. Veterinary professionals are focusing on preventive care and early disease detection to maintain the performance and well-being of horses. Additionally, technological advancements in veterinary diagnostics and treatment methods are improving the overall quality of equine healthcare services.

In the coming years, the Global Equine Healthcare Market is expected to expand as equine sports and recreational activities continue to grow worldwide. Increased investment in veterinary infrastructure and research is supporting the development of innovative healthcare solutions for horses. As horse owners increasingly prioritize animal health and welfare, the demand for specialized equine healthcare services is likely to rise.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Drug Class (Anti-Infective, Anti-Inflammatory, Parasiticides, Others)
• Vaccines (Inactivated, Live Attenuated, Recombinant, Others)
• Supplemental Feed Additives

By Disease Type

• West Nile Virus
• Equine Rabies
• Equine Influenza
• Equine Herpes Virus
• Potomac Horse Fever
• Tetanus
• Others

By Distribution Channel

• Veterinary Hospitals And Clinics
• Retail Pharmacies And Drug Stores
• Others

COMPANIES PROFILED

• Zoetis Inc, Ceva Sant Animale, Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Vetoquinol, Neogen Corporation, Virbac, Merck Co Inc, Norbrook Laboratories Ltd, Purina Animal Nutrition LLC, Kyoritsuseiyaku Corporation, Equine Products UK Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EQUINE HEALTHCARE MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Drug Class (Anti-Infective, Anti-Inflammatory, Parasiticides, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Vaccines (Inactivated, Live Attenuated, Recombinant, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Supplemental Feed Additives Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EQUINE HEALTHCARE MARKET: BY DISEASE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Disease Type
• 5.2. West Nile Virus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Equine Rabies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Equine Influenza Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Equine Herpes Virus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Potomac Horse Fever Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Tetanus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EQUINE HEALTHCARE MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Veterinary Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies And Drug Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EQUINE HEALTHCARE MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Disease Type
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Disease Type
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Disease Type
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Disease Type
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Disease Type
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL EQUINE HEALTHCARE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Zoetis Inc
  • 9.2.2 Ceva SantAfA(C) Animale
  • 9.2.3 Elanco Animal Health Incorporated
  • 9.2.4 Boehringer Ingelheim International GmbH
  • 9.2.5 Vetoquinol
  • 9.2.6 Neogen Corporation
  • 9.2.7 Virbac
  • 9.2.8 Merck & Co. Inc
  • 9.2.9 Norbrook Laboratories Ltd
  • 9.2.10 Purina Animal Nutrition LLC
  • 9.2.11 Kyoritsuseiyaku Corporation
  • 9.2.12 Equine Products UK Ltd